X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1471) 1471
Publication (136) 136
Magazine Article (7) 7
Book Review (6) 6
Book Chapter (4) 4
Book / eBook (3) 3
Conference Proceeding (2) 2
Newsletter (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
peritonitis - chemically induced (1015) 1015
animals (961) 961
male (750) 750
humans (677) 677
mice (570) 570
female (516) 516
index medicus (420) 420
rats (364) 364
inflammation (293) 293
peritonitis (293) 293
peritonitis - pathology (272) 272
peritonitis - drug therapy (262) 262
middle aged (234) 234
disease models, animal (229) 229
peritonitis - immunology (222) 222
peritonitis - metabolism (189) 189
immunology (183) 183
mice, inbred c57bl (179) 179
adult (175) 175
aged (170) 170
pharmacology & pharmacy (148) 148
rats, wistar (125) 125
time factors (116) 116
macrophages (109) 109
mice, knockout (107) 107
urology & nephrology (107) 107
zymosan (103) 103
cell biology (100) 100
peritonitis - etiology (98) 98
peritonitis - prevention & control (94) 94
anti-inflammatory agents - pharmacology (93) 93
inflammation - chemically induced (88) 88
cells, cultured (87) 87
injections, intraperitoneal (87) 87
carrageenan (86) 86
rats, sprague-dawley (86) 86
expression (85) 85
mice, inbred balb c (84) 84
edema - chemically induced (83) 83
peritonitis - physiopathology (83) 83
surgery (83) 83
neutrophils - immunology (79) 79
acute disease (78) 78
neutrophils (78) 78
research article (75) 75
neutrophils - metabolism (74) 74
hematology (71) 71
peritonitis - complications (71) 71
biochemistry & molecular biology (70) 70
dose-response relationship, drug (69) 69
peritonitis - microbiology (68) 68
cells (67) 67
neutrophils - drug effects (67) 67
activation (64) 64
analysis (64) 64
cytokines (64) 64
peritoneum - pathology (64) 64
peritoneal dialysis (61) 61
in-vivo (60) 60
gastroenterology & hepatology (58) 58
macrophages - drug effects (58) 58
peritonitis - surgery (57) 57
practolol - adverse effects (57) 57
sepsis (57) 57
zymosan - toxicity (57) 57
anti-inflammatory agents, non-steroidal - pharmacology (56) 56
peritonitis - diagnosis (56) 56
macrophages - metabolism (55) 55
chemistry, medicinal (53) 53
starch - adverse effects (53) 53
anti-inflammatory agents - therapeutic use (52) 52
thioglycolates (52) 52
inflammation - metabolism (51) 51
rodents (51) 51
macrophages - immunology (50) 50
nitric-oxide (50) 50
inflammation - pathology (49) 49
research (49) 49
article (48) 48
cytokines - metabolism (48) 48
health aspects (48) 48
inflammation - immunology (48) 48
pathology (48) 48
peritonitis - genetics (48) 48
rat (46) 46
inflammation - drug therapy (45) 45
lipopolysaccharides (45) 45
apoptosis (44) 44
edema - drug therapy (44) 44
random allocation (44) 44
cell line (43) 43
inhibition (43) 43
leukocyte count (43) 43
gloves, surgical (42) 42
leukocytes - drug effects (41) 41
medicine, research & experimental (41) 41
multidisciplinary sciences (41) 41
in-vitro (40) 40
leukocytes (40) 40
rabbits (40) 40
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1336) 1336
German (32) 32
Russian (28) 28
French (22) 22
Spanish (17) 17
Ukrainian (10) 10
Japanese (6) 6
Dutch (5) 5
Italian (5) 5
Polish (4) 4
Chinese (3) 3
Danish (3) 3
Hungarian (2) 2
Korean (2) 2
Swedish (2) 2
Croatian (1) 1
Czech (1) 1
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 03/2006, Volume 440, Issue 7081, pp. 237 - 241
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 78 - 89
Summary Background Angiogenesis is a target in the treatment of ovarian cancer. Nintedanib, an oral triple angiokinase inhibitor of VEGF receptor,... 
Hematology, Oncology and Palliative Medicine | BIBF 1120 | DES CANCERS | INTERGROUP TRIAL | LABEL DOSE-ESCALATION | CISPLATIN | ONCOLOGY | BEVACIZUMAB | TRIPLE ANGIOKINASE INHIBITOR | CARBOPLATIN PLUS PACLITAXEL | III TRIAL | MAINTENANCE THERAPY | Humans | Middle Aged | Ovarian Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Response Evaluation Criteria in Solid Tumors | Diarrhea - chemically induced | Cytoreduction Surgical Procedures | Indoles - administration & dosage | Young Adult | Peritoneal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Carcinoma - pathology | Neutropenia - chemically induced | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Double-Blind Method | Carcinoma - surgery | Peritoneal Neoplasms - surgery | Anemia - chemically induced | Carboplatin - administration & dosage | Fallopian Tube Neoplasms - pathology | Thrombocytopenia - chemically induced | Disease Progression | Disease-Free Survival | Indoles - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Fallopian Tube Neoplasms - surgery | Intention to Treat Analysis | Aged | Neoplasm Staging | Ovarian Neoplasms - surgery | Clinical trials | Chemotherapy | Hospitals | Growth factors | Cancer | Ovarian cancer | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal Article
Journal of Ethnopharmacology, ISSN 0378-8741, 09/2015, Volume 173, pp. 127 - 133
Journal Article
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 03/2007, Volume 9, Issue 2, pp. R28 - R28
Journal Article
Journal Article